
According to the American Cancer Society, nearly 1 in 8 men will be diagnosed with prostate cancer during their lifetime. The reassuring news is that with advancements in medical science, especially in the field of prostate cancer radiation therapy, long-term survival and quality of life are significantly improving. At the forefront of this evolution is Dr. Mathangi J, Senior Consultant & In-charge of Radiation Oncology at Gleneagles Cancer Institute, Bangalore. With more than 20 years of experience and over 12,000 patients treated, Dr. Mathangi is redefining outcomes for men battling prostate cancer.
Prostate cancer treatment involves multiple approaches depending on the stage and spread of the disease. While surgery and hormone therapy play roles, radiation therapy is often the most precise and organ-preserving option. Dr. Mathangi specializes in delivering targeted therapies that minimize side effects while maximizing tumor control.
Her expertise in advanced technologies like SBRT for prostate cancer (Stereotactic Body Radiation Therapy), Gated RapidArc, and image-guided interstitial brachytherapy ensures that treatment is tailored to the patient's anatomy and cancer biology.
When you hear the phrase radiation therapy for prostate cancer treatment, it refers to the controlled delivery of high-energy radiation beams directly to the prostate gland. This disrupts the cancer cell’s DNA, preventing it from multiplying further. The sophistication of the technique used can make a major difference in outcomes.
At Gleneagles Cancer Institute, Dr. Mathangi leverages technologies like TrueBeam STx — Asia Pacific's first installation — to deliver radiation with sub-millimeter precision. This results in:
The term radiation to treat prostate cancer includes several types of radiation techniques. Dr. Mathangi's approach includes:
These techniques are selected based on tumor grade, PSA levels, Gleason score, and patient health. The goal is to balance eradication of cancer with preservation of normal function — something Dr. Mathangi achieves with a patient-first philosophy.
The decision to go for prostate cancer and radiation therapy is a pivotal one. But when under the guidance of a specialist like Dr. Mathangi, the journey becomes far less daunting. Here’s why patients from across India and even international patients seek her expertise:
Her international training from Germany, Denmark, and 4EIEVSEN further equips her to deliver results on par with global oncology leaders.
Let’s walk through what a typical radiation procedure for prostate cancer involves under Dr. Mathangi’s care:
During the course, patients often find comfort in knowing they’re under the care of a physician who has helped over 12,000 others through similar journeys.
While today’s techniques are far more refined, some temporary side effects from prostate cancer radiation therapy may include:
Dr. Mathangi’s team ensures proactive management of symptoms through medications, dietary guidance, and counseling.
The longer prostate cancer remains untreated, the higher the chances it will spread beyond the prostate. Radiation is most effective when cancer is localized. If you or your loved one has been recently diagnosed, a timely consult with Dr. Mathangi could make a world of difference.
Ready to take the first step toward expert-led radiation to treat prostate cancer? Submit your contact details via the appointment form at https://drmathangi.com/contact/. Dr. Mathangi’s team will promptly reach out to confirm your appointment and help you prepare for your visit to Gleneagles Cancer Institute, Bangalore.
While prostate cancer is a major area of specialization, Dr. Mathangi also offers radiation therapy for:
Her approach to care extends across cancer types — always with precision, empathy, and patient dignity at the core.
Prostate cancer radiation therapy is a non-invasive treatment that uses high-energy rays or particles to kill cancer cells in the prostate gland. This method targets the tumor while preserving surrounding healthy tissue, offering an effective alternative to surgery for many patients.
Yes, prostate cancer treatment using radiation has a high success rate, especially when detected early. Under the expert care of Dr. Mathangi at Gleneagles Cancer Institute, advanced radiation techniques are used to ensure precise targeting of cancer cells with minimal side effects.
Radiation therapy for prostate cancer treatment is non-surgical and usually does not require hospitalization. It is ideal for patients who want to avoid the risks and recovery period associated with prostate surgery, and it can often preserve sexual and urinary functions more effectively.
Dr. Mathangi offers several advanced options for radiation to treat prostate cancer, including image-guided radiotherapy (IGRT), stereotactic body radiation therapy (SBRT), RapidArc, and brachytherapy. These methods allow for accurate radiation delivery with fewer sessions and reduced side effects.
Common side effects of prostate cancer and radiation therapy include mild urinary issues, bowel changes, fatigue, and, in some cases, temporary sexual dysfunction. However, with Dr. Mathangi’s precision-based approach, most patients experience minimal discomfort and quick recovery.
During a radiation procedure for prostate cancer, patients first undergo a planning session (simulation) to map the tumor using advanced imaging. The treatment is then carried out over several outpatient sessions. Dr. Mathangi uses cutting-edge technology like TrueBeam STx to ensure each dose precisely targets the cancer.
Most patients receiving prostate cancer radiation therapy can continue daily routines with minimal disruption. Since it is an outpatient treatment, there is typically no need for hospital admission, and side effects, if any, are manageable with supportive care.
To consult Dr. Mathangi regarding your prostate cancer treatment options, you can submit your contact details at this appointment form. Her team will get in touch with you to schedule your consultation at Gleneagles Cancer Institute in Bangalore.
Your information is kept strictly confidential.